Associate Vice President - Pharmacoepidemiology
Eli Lilly and Company
Indiainapolis, United States
Biography
Kenneth Hornbuckle, DVM, MPH, PhD, FISPE
Associate Vice President, Pharmacoepidemiology
Global Patient Safety
Eli Lilly and Company
Kenneth Hornbuckle, DVM, MPH, PhD, FISPE is an Associate Vice President for the Pharmacoepidemiology Group which is a component within the Global Patient Safety Organization at Eli Lilly and Company. He has over 25 years of experience in pharmacovigilance, drug safety surveillance, pharmacoepidemiology, benefit-risk assessment and risk management plans. Dr. Hornbuckle currently leads the Pharmacoepidemiology Team to provide pharmacoepidemiological and observational research expertise to support drug safety assessments and benefit-risk management across the Company’s portfolio. He also has extensive experience leveraging RWD/RWE for decision making, fulfilling PMRs/PMCs, and collaborating on various cross-industry RWD/RWE initiatives. Dr. Hornbuckle received a Doctor of Veterinary Medicine (DVM) from Tuskegee University and a MPH, PhD (epidemiologic science) from the University of Michigan, School of Public Health.
Disclosure information not submitted.
Hali-FACTS: Navigating Benefit-Risk Decision-Making with RWE (sponsored by BRACE SIG)
Sunday, August 27, 2023
1:30 PM – 3:00 PM ADT
